The first factor is vaccine durability, or the length of protection against the virus. This can be determined by looking at the correlates of immunity for a cohort of vaccinated individuals and ensuring these metrics don’t go below a critical baseline.
The second factor is how many breakthrough infections are occurring among vaccinated people. A rise in breakthrough infections would suggest decreasing immunity, according to Dr. Fauci.
“We hope we don’t get to that point, [that] we’ll know about it before,” he said.
Clinical trials for COVID-19 vaccine boosters against the “wild type” of the virus and specific variants are ongoing, Dr. Fauci said.
Ultimately, the timeline for a potential booster is still unclear.
“That could be a year. That could be 18 months. That could be much longer,” Dr. Fauci said. “We’re going to have to follow it. And we will act according to the information that we get from the parameters that I just mentioned.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
